Studies indicate that a significant proportion of patients live to regret saying ‘yes’ to cancer treatments because of the impact on how they look, function or feel. Simon Crompton talks to patients and physicians about [more]
Roger Wilson is a leading voice in cancer patient advocacy. He has been living with a recurrent sarcoma for 20 years, and is a co-founder of Sarcoma Patients Euronet. He is on the faculty of [more]
Cardiovascular disease remains the leading cause of mortality among middle aged adults globally, accounting for 40% of all deaths, but in high-income countries cancer is now responsible for twice as many deaths as CVD (55% vs 23%), according to a new report from the Prospective Urban and Rural Epidemiologic (PURE) study published in The Lancet. [more]
In women diagnosed with first primary breast cancer (BC), a closer look to epigenetic might be the “ace in the hole” to better understand the link between Aspirin use and prognosis and to refine patients stratification and risk-reducing strategies. Findings from a study recently published in Cancer suggest that the [more]
Results from studies on PARP inhibitors show that BRCA status and responsiveness to platinum analogues are much less binding that it was thought to achieve some improvements. But more clinical trials are needed to decide if PARP inhibitors should be used as part of first-line therapy or reserved for a later line [more]